Lorena Ibanez

Journal Article
A1
open access

Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies

Teodora-Eugenia Oltean (UGent) , Lorena Ibanez (UGent) , Tatyana Divert (UGent) , Tine Ysenbaert (UGent) , Hannelore Van Eeckhoutte (UGent) , Vera Goossens (UGent) , Michael Schotsaert (UGent) , Ken Bracke (UGent) , Bert Schepens (UGent) , Jonathan Maelfait (UGent) , et al.

(2022) CELL DEATH & DISEASE. 13(3).

Add to list

Journal Article
A1
open access

Reverse engineering synthetic antiviral amyloids

Emiel Michiels, Kenny Roose (UGent) , Rodrigo Gallardo, Ladan Khodaparast, Laleh Khodaparast, Rob van der Kant, Maxime Siemons, Bert Houben, Meine Ramakers, Hannah Wilkinson, et al.

(2020) NATURE COMMUNICATIONS. 11(1).

Add to list

Antibodies directed toward neuraminidase N1 control disease in a mouse model of influenza

Emma Job (UGent) , Michael Schotsaert (UGent) , Lorena Ibanez (UGent) , Anouk Smet (UGent) , Tine Ysenbaert (UGent) , Kenny Roose (UGent) , M. Dai, C. A. M. de Haan, H. Kleanthous, T. U. Vogel, et al.

(2018) JOURNAL OF VIROLOGY. 92(4).

Add to list

Journal Article
A1
open access

A20 deficiency in lung epithelial cells protects against influenza A virus infection

Jonathan Maelfait (UGent) , Kenny Roose (UGent) , Lars Vereecke (UGent) , Conor Mc Guire (UGent) , Mozes Sze (UGent) , Martijn Schuijs (UGent) , Monique Willart (UGent) , Lorena Ibanez (UGent) , Hamida Hammad (UGent) , Bart Lambrecht (UGent) , et al.

(2016) PLOS PATHOGENS. 12(1).

Add to list

Journal Article
A1
open access

Protection against influenza A virus challenge with M2e-displaying filamentous Escherichia coli phages

Lei Deng (UGent) , Lorena Ibanez (UGent) , VERONIQUE VAN DEN BOSSCHE (UGent) , Kenny Roose (UGent) , Sameh A Youssef, Alain de Bruin, Walter Fiers and Xavier Saelens (UGent)

(2015) PLOS ONE. 10(5).

Add to list

Influenza vaccines to control influenza-associated bacterial infection: where do we stand?

Ioanna Christopoulou (UGent) , Kenny Roose (UGent) , Lorena Ibanez (UGent) and Xavier Saelens (UGent)

(2015) EXPERT REVIEW OF VACCINES. 14(1). p.55-67

Add to list

Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge

Miguel Lopez Cardoso (UGent) , Lorena Ibanez (UGent) , Silvie Van den Hoecke (UGent) , Sarah De Baets (UGent) , Anouk Smet (UGent) , Kenny Roose (UGent) , Bert Schepens (UGent) , Francis Descamps (UGent) , Walter Fiers, Serge Muyldermans, et al.

(2014) JOURNAL OF VIROLOGY. 88(15). p.8278-8296

Add to list

Natural and long-lasting cellular immune responses against influenza in the M2e-immune host

Michael Schotsaert (UGent) , Tine Ysenbaert (UGent) , Kristien Neyts (UGent) , Lorena Ibanez (UGent) , Pieter Bogaert (UGent) , Bert Schepens (UGent) , Bart Lambrecht (UGent) , Walter Fiers and Xavier Saelens (UGent)

(2013) MUCOSAL IMMUNOLOGY. 6(2). p.276-287

Add to list

Journal Article
A1
open access

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A

Lorena Ibanez (UGent) , Kenny Roose (UGent) , Marina De Filette, Michael Schotsaert (UGent) , Jessica De Sloovere, Stefan Roels, Charlotte Pollard (UGent) , Bert Schepens (UGent) , Johan Grooten (UGent) , Walter Fiers, et al.

(2013) PLOS ONE. 8(3).

Add to list

Book Chapter
open access

Single domain camelid antibodies that neutralize negative strand viruses

Miguel Lopez Cardoso (UGent) , Lorena Ibanez (UGent) , Bert Schepens (UGent) and Xavier Saelens (UGent)

(2012) Antiviral drugs : aspects of clinical use and recent advances. p.151-170

Academic Bibliography

Lorena Ibanez

Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies

Reverse engineering synthetic antiviral amyloids

Antibodies directed toward neuraminidase N1 control disease in a mouse model of influenza

A20 deficiency in lung epithelial cells protects against influenza A virus infection

Protection against influenza A virus challenge with M2e-displaying filamentous Escherichia coli phages

Influenza vaccines to control influenza-associated bacterial infection: where do we stand?

Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge

Natural and long-lasting cellular immune responses against influenza in the M2e-immune host

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A

Single domain camelid antibodies that neutralize negative strand viruses

Contents

Support

Contact